H

Hemant Surgical Industries Ltd
BSE:543916

Watchlist Manager
Hemant Surgical Industries Ltd
BSE:543916
Watchlist
Price: 18.08 INR -93.93% Market Closed
Market Cap: 94.5m INR

Profitability Summary

Hemant Surgical Industries Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Hemant Surgical Industries Ltd

Revenue
1.1B INR
Cost of Revenue
-765.6m INR
Gross Profit
300.8m INR
Operating Expenses
-206.3m INR
Operating Income
94.5m INR
Other Expenses
-14.1m INR
Net Income
80.4m INR

Margins Comparison
Hemant Surgical Industries Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IN
Hemant Surgical Industries Ltd
BSE:543916
94.5m INR
28%
9%
8%
US
Mckesson Corp
NYSE:MCK
102.7B USD
3%
1%
1%
US
Amerisourcebergen Corp
LSE:0HF3
66.2B USD
4%
1%
0%
US
Cencora Inc
NYSE:COR
66.1B USD
4%
1%
0%
US
Cardinal Health Inc
NYSE:CAH
49.6B USD
4%
1%
1%
AU
Sigma Healthcare Ltd
ASX:SIG
34.3B AUD
24%
12%
9%
CN
Huadong Medicine Co Ltd
SZSE:000963
69.6B CNY
33%
11%
9%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
66.2B CNY
10%
3%
2%
US
Henry Schein Inc
NASDAQ:HSIC
9B USD
31%
6%
3%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
30%
9%
7%
CN
Sinopharm Group Co Ltd
HKEX:1099
60.8B HKD
7%
3%
1%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Hemant Surgical Industries Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IN
Hemant Surgical Industries Ltd
BSE:543916
94.5m INR
14%
7%
13%
9%
US
Mckesson Corp
NYSE:MCK
102.7B USD
-170%
5%
35%
24%
US
Amerisourcebergen Corp
LSE:0HF3
66.2B USD
144%
2%
24%
17%
US
Cencora Inc
NYSE:COR
66.1B USD
144%
2%
24%
17%
US
Cardinal Health Inc
NYSE:CAH
49.6B USD
-52%
3%
23%
17%
AU
Sigma Healthcare Ltd
ASX:SIG
34.3B AUD
19%
11%
19%
14%
CN
Huadong Medicine Co Ltd
SZSE:000963
69.6B CNY
16%
10%
19%
14%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
66.2B CNY
8%
2%
8%
4%
US
Henry Schein Inc
NASDAQ:HSIC
9B USD
11%
4%
10%
6%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
7%
3%
9%
5%
CN
Sinopharm Group Co Ltd
HKEX:1099
60.8B HKD
9%
2%
12%
5%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less